Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

In vitro modulatory effects of Andrographis paniculata, Centella asiatica and Orthosiphon stamineus on cytochrome P450 2C19 (CYP2C19).

Authors:
Yan Pan Badrul Amini Abd-Rashid Zakiah Ismail Rusli Ismail Joon Wah Mak Peter C K Pook Hui Meng Er Chin Eng Ong

J Ethnopharmacol 2011 Jan 18;133(2):881-7. Epub 2010 Nov 18.

School of Pharmacy and Health Sciences, International Medical University, 126 Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia.

Ethno Pharmacological Relevance: Andrographis paniculata (AP), Centella asiatica (CA) and Orthosiphon stamineus (OS) are three popular herbs traditionally used worldwide. AP is known for the treatment of infections and diabetes and CA is good for wound healing and healthy skin while OS is usually consumed as tea to treat kidney and urinary disorders. Interaction of these herbs with human cytochrome P450 2C19 (CYP2C19), a major hepatic CYP isoform involved in metabolism of many clinical drugs has not been investigated to date.

Aim Of The Study: In this study, the modulatory effects of various extracts and major active constituents of AP, CA and OS on CYP2C19 activities were evaluated.

Materials And Methods: S-mephenytoin, the CYP2C19 substrate probe, was incubated in the presence or absence of AP, CA and OS components. The changes in the rate of metabolite (hydroxymephenytoin) formation were subsequently determined by a high-performance liquid chromatography (HPLC)-based enzyme assay to characterize the modulatory effects.

Results: Among the herbal extracts studied, AP ethanol extract and CA dichloromethane extract exhibited mixed type inhibition towards CYP2C19 with K(i) values of 67.1 and 16.4 μg/ml respectively; CA ethanol extract and OS petroleum ether extract competitively inhibited CYP2C19 activity (K(i)=39.6 and 41.5 μg/ml respectively). Eupatorin (a major active constituent of OS) was found to significantly inhibit CYP2C19 by mixed type inhibition (K(i)=7.1 μg/ml or 20.6 μM).

Conclusions: It was observed that AP, CA and OS inhibited CYP2C19 activity with varying potency. While weak inhibitory effect was observed with AP, moderate to strong inhibition was observed with CA dichloromethane extract and eupatorin, the major OS constituent. Therefore care should be taken when these CA and OS components are co-administered with CYP2C19 substrates (such as omeprazole, proguanil, barbiturates, citalopram, and diazepam).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2010.11.026DOI Listing
January 2011

Publication Analysis

Top Keywords

cyp2c19
9
inhibited cyp2c19
8
orthosiphon stamineus
8
asiatica orthosiphon
8
dichloromethane extract
8
ethanol extract
8
cytochrome p450
8
eupatorin major
8
2c19 cyp2c19
8
p450 2c19
8
centella asiatica
8
cyp2c19 activity
8
type inhibition
8
major active
8
mixed type
8
modulatory effects
8
paniculata centella
8
andrographis paniculata
8
extract
5
effectsresults herbal
4

Keyword Occurance

Similar Publications

Aspirin plus ticagrelor or clopidogrel on graft patency one year after coronary bypass grafting: a single-center, randomized, controlled trial.

Authors:
Yangfeng Tang Xinli Fan Boyao Zhang Jiajun Zhang Qin Xue Zhiyun Xu Lin Han

J Thorac Dis 2021 Mar;13(3):1697-1705

Department of Cardiothoracic Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, China.

Background: Dual antiplatelet therapy (DAPT) improves early post-operative graft patency, but the optimal DAPT strategy for the patients after coronary artery bypass grafting (CABG) has not been confirmed. We sought to evaluate the effect of aspirin plus ticagrelor versus aspirin plus clopidogrel on saphenous vein graft (SVG) patency within 1 year after CABG.

Methods: Between October 2017 and December 2018, 147 consecutive patients undergoing elective CABG at Changhai Hospital were randomized into two groups: group AT, receiving aspirin 100 mg/d plus ticagrelor 2×90 mg/d; group AC, receiving aspirin 100 mg/d plus clopidogrel 75 mg/d. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan.

Authors:
Rika Wakao Ingrid M Lönnstedt Yasunori Aoki Rebecca E Chandler

Drug Saf 2021 Apr 10. Epub 2021 Apr 10.

Uppsala Monitoring Centre, Box 1051, 75140, Uppsala, Sweden.

Introduction: Genetic variations of enzymes that affect the pharmacokinetics and hence effects of medications differ between ethnicities, resulting in variation in the risk of adverse drug reactions (ADR) between different populations. Previous work has demonstrated that risk-group considerations can be incorporated into approaches of statistical signal detection. It is unknown whether databases of individual case safety reports (ICSRs) are sensitive to pharmacogenomic differences between populations. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Effects of Tianma (Rhizoma Gastrodiae) and Gouteng (Ramulus Uncariae Rhynchophyllae cum Uncis) on cytochrome P450 enzyme activities in rats.

Authors:
Xin Liu Xinyu Wang Yinxuan Peng Xing Wang

J Tradit Chin Med 2021 04;41(2):284-292

College of Medicine, Southwest Jiaotong University, Chengdu 610031, China.

Objective: To investigate the efficacy of Tianma (Rhizoma Gastrodiae) and Gouteng (Ramulus Uncariae Rhynchophyllae cum Uncis) on cytochrome P450 (CYP450) enzyme activities in rats.

Methods: A cocktail strategy was followed to evaluate the influence of Tianma (Rhizoma Gastrodiae) and Gouteng (Ramulus Uncariae Rhynchophyllae cum Uncis) on the activities of CYP450 isoforms (CYP1A2, CYP3A4, CYP2E1, CYP2C19, CYP2C9, CYP2D6), which were determined by changes in the pharmacokinetic parameters of six probe drugs, theophylline, dapsone, chlorzoxazone, omeprazole, tolbutamide and dextromethorphan. Study groups included, Control group (CG), Tianma (Rhizoma Gastrodiae) group (TM), Gouteng (Ramulus Uncariae Rhynchophyllae cum Uncis) group (GT) and Tianma Gouteng (Gastrodia Uncaria) group (TMGT). Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Trichostatin A sensitizes hepatoma cells to Taxol more than 5-Aza-dC and dexamethasone.

Authors:
Thoria Donia Sherien Khedr Elsayed I Salim Mohamed Hessien

Drug Metab Pers Ther 2021 Apr 5. Epub 2021 Apr 5.

Division of Biochemistry, Department of Chemistry, Faculty of Science, Tanta University, Tanta, Egypt.

Objectives: This work was designed to compare the sensitizing effects of epigenetic modifiers on cancer cells vs. that of glucocorticoids. Also, to evaluate their effects on genes involved in epigenetic changes and drug metabolism. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations.

Authors:
Chad A Bousman Patrick Wu Katherine J Aitchison Tony Cheng

Front Pharmacol 2021 18;12:636650. Epub 2021 Mar 18.

Ushiosoft Corporation, Calgary, AB, Canada.

Pharmacogenomic (PGx) testing has emerged as an effective strategy for informing drug selection and dosing. This has led to an increase in the use of PGx testing in the clinic and has catalyzed the emergence of a burgeoning commercial PGx testing industry. However, not all PGx tests are equivalent in their approach to translating testing results into prescribing recommendations, due to an absence of regulatory standards. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap